期刊文献+

氨·环己胺·羧酸根合铂(Ⅱ)类配合物的合成、抗肿瘤活性和与DNA的键合水平(英文) 被引量:1

Synthesis, Cytotoxicity and DNA-Binding Levels of Amminecyclohexy/Aminecarboxy/Platinum (Ⅱ)Complexes
下载PDF
导出
摘要 本工作设计合成了6种新型氨·环己胺·羧酸根合铂!类配合物[Pt(NH3)(NH2)X2](a ̄f){其中,X=CH3COO-(乙酸根),CH2ClCOO-(氯乙酸根),C6H5-COO-(苯甲酸根),p-CH3O-C6H4-COO-(对甲氧基苯甲酸根),p-CH3-C6H4-COO-(对甲基苯甲酸根),p-NO2-C6H4-COO-(对硝基苯甲酸根)}。通过元素分析、摩尔电导、红外光谱、紫外光谱和1H核磁共振谱对配合物进行了表征。通过MTT法研究了配合物的体外抗肿瘤活性,通过流式细胞仪以及等离子体质谱研究了配合物对细胞周期的影响以及与细胞DNA的键合量;体外抗肿瘤活性测试表明,配合物(c ̄f)对EJ和HL-602种肿瘤细胞表现出好的活性,而且配合物(c),(d)和(e)对EJ和HL-602种肿瘤细胞的活性高于临床用药顺铂;配合物(a ̄f)对MCF-7、HCT-8和BGC-8233种肿瘤细胞的活性低于顺铂;它们能阻止HL-60和EJ细胞G2+M→G1期的进行;配合物(a ̄f)与HL-60和EJ细胞的DNA键合量从大到小的顺序为:c>d>e>cisplatin>f>a>b。 Six new amminecyclohexy/aminecarboxy/platinum(lI) complexes with carboxylates (a-f) have been synthesized and characterized by elemental analysis, conductivity, IR, UV, and ^1H NMR spectra techniques. The cytotoxicity of the complexes was tested by MTI' assay. The cell cycle analysis and the levels of total platinum bound to DNA were measured by flow cytometry and ICP-MS. The results show that complexes (c), (d), (e) and (f) have excellent cytotoxicity against EJ and HL-60 and complexes (c), (d) and (e) demonstrate cytotoxicity superior to that of the clinically established cisplatin. Complexes (a-f) have poor cytotoxicity against HCT-8, MCF-7 and BGC-823 than that of cisplatin. The complexes (a-f) induce a concentration-dependent accumulation of HL-60 and EJ cells in the G2/M phase of the cell cycle as cisplatin. The levels of total platinum bound to DNA in HL- 60 and EJ cells decrease in the sequence: c 〉 d 〉 e 〉 cisplatin 〉 f 〉 a 〉 b under the same experimental condi- tions. Key words: mixed amine platinum(H) complexes; antitumor activity; classical structure-activity relationships; cell cycle; Pt-DNA binding
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2006年第5期823-831,共9页 Chinese Journal of Inorganic Chemistry
关键词 混胺铂(Ⅱ)配合物 抗肿瘤活性 经典构效关系 细胞周期 Pt-DNA键合 mixed amine platinum(Ⅱ) complexes antitumor activity classical structure-activity relationships cell cycle Pt-DNA binding
  • 相关文献

参考文献34

  • 1Sadler P J, Guo Z J. Pure & Appl. Chem., 1998,70(4):863- 871.
  • 2Wong E, Giandomenico C M. Chem. Rev., 1999,99:2451- 2466,
  • 3Ho Y P, Au-Yeung S C F, Kenneth K W T. Med. Res. Rev., 2003,23(5):633-655.
  • 4Jakupec M A, Galanski M, Keppler B K. Rev. Physiol. Biochem. Pharmacol., 2003,146:1-53.
  • 5Boulikas T, Vougiouka M. Oncology Rep., 2003,10:1663- 1682.
  • 6Tang W X, Qu J, Dai A B, et al. Nanjing Daxue Xuebao, Ziran Kexue Ban(Journal of Nanjing University, Natural Science Edition), 1984,3:471-478.
  • 7Wang L H, Liu Y, Yuan F P, et al. Wuji Huaxue Xuebao (Chinese J. Inorg. Chem.), 2004,20(7):775-780.
  • 8Yang P, Guo M L. Coord. Chem. Rev., 1999,185-186:189- 211.
  • 9Wang K. Pure & Appl. Chem., 1988,60:1279-1285.
  • 10Zhang J C, Gong Y Q, Zheng X M. Synth. React. Inorg. Met.-Org. Chem., 2002,32(1):49-57.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部